IRIS
MORONCINI, Gianluca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.742
EU - Europa 4.212
AS - Asia 3.926
SA - Sud America 1.063
AF - Africa 246
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 7
Totale 17.207
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.548
SG - Singapore 1.208
IT - Italia 925
VN - Vietnam 891
BR - Brasile 844
RU - Federazione Russa 722
CN - Cina 653
DE - Germania 443
UA - Ucraina 418
HK - Hong Kong 409
SE - Svezia 325
IE - Irlanda 311
FR - Francia 267
TR - Turchia 193
FI - Finlandia 166
GB - Regno Unito 161
DK - Danimarca 149
IN - India 109
CI - Costa d'Avorio 96
CA - Canada 84
KR - Corea 82
NL - Olanda 78
MX - Messico 73
AR - Argentina 68
BD - Bangladesh 64
PL - Polonia 54
AT - Austria 48
JP - Giappone 48
ZA - Sudafrica 48
EC - Ecuador 46
IQ - Iraq 39
MA - Marocco 38
ES - Italia 35
PK - Pakistan 33
ID - Indonesia 32
CO - Colombia 28
VE - Venezuela 21
BE - Belgio 19
CL - Cile 19
IL - Israele 17
PY - Paraguay 17
TN - Tunisia 17
UZ - Uzbekistan 17
PH - Filippine 15
SA - Arabia Saudita 15
MY - Malesia 12
EG - Egitto 11
LT - Lituania 11
AE - Emirati Arabi Uniti 10
DZ - Algeria 10
NP - Nepal 10
AL - Albania 9
JO - Giordania 9
AU - Australia 8
PE - Perù 8
RS - Serbia 8
UY - Uruguay 8
CH - Svizzera 7
DO - Repubblica Dominicana 7
KE - Kenya 7
PS - Palestinian Territory 7
RO - Romania 7
TW - Taiwan 7
CR - Costa Rica 6
AZ - Azerbaigian 5
EE - Estonia 5
ET - Etiopia 5
EU - Europa 5
HN - Honduras 5
KZ - Kazakistan 5
NI - Nicaragua 5
OM - Oman 5
BA - Bosnia-Erzegovina 4
CZ - Repubblica Ceca 4
GR - Grecia 4
HR - Croazia 4
JM - Giamaica 4
KW - Kuwait 4
LB - Libano 4
NO - Norvegia 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
BO - Bolivia 3
GE - Georgia 3
GT - Guatemala 3
HU - Ungheria 3
IR - Iran 3
MD - Moldavia 3
GA - Gabon 2
KG - Kirghizistan 2
LU - Lussemburgo 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
PA - Panama 2
SI - Slovenia 2
SN - Senegal 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 17.179
Salva come PNG Salva come JPEG
Città #
Ashburn 1.327
Singapore 745
Chandler 621
Dallas 520
San Jose 472
Jacksonville 428
Hong Kong 397
Fairfield 334
Ho Chi Minh City 306
Dublin 305
Boardman 287
Des Moines 264
New York 212
Hanoi 195
Wilmington 190
The Dalles 188
Beijing 178
Los Angeles 161
Woodbridge 155
Houston 152
Centro 149
Lauterbourg 146
Munich 133
Seattle 133
Moscow 132
Ann Arbor 115
Lawrence 108
Princeton 108
Ancona 97
Abidjan 96
San Mateo 92
São Paulo 91
Cambridge 80
Hefei 80
Council Bluffs 65
Chicago 64
Orem 59
Helsinki 55
Nuremberg 51
Buffalo 45
Redmond 45
Santa Clara 45
London 44
Da Nang 41
Haiphong 41
Turin 41
Turku 38
Warsaw 38
Milan 37
Tokyo 37
Mexico City 35
San Diego 35
Frankfurt am Main 33
Montreal 32
Shanghai 32
Rio de Janeiro 31
Marche 30
Tolentino 30
Chennai 29
Johannesburg 28
Atlanta 27
Salt Lake City 26
Amsterdam 24
Rome 24
Brasília 23
Washington 23
Brooklyn 22
Guangzhou 21
Poplar 20
Stockholm 20
Vienna 20
Belo Horizonte 19
Denver 18
Jesi 17
Porto Alegre 17
Phoenix 16
Pune 16
Boston 15
Columbus 15
Curitiba 15
Manchester 15
Tashkent 15
Wuhan 15
Brussels 14
Guayaquil 14
San Francisco 14
Guarulhos 13
Sterling 13
Ankara 12
Baghdad 12
Biên Hòa 12
Bắc Ninh 12
Hải Dương 12
Jiaxing 12
Elk Grove Village 11
Falls Church 11
Kilburn 11
Quito 11
Bến Tre 10
Florence 10
Totale 10.705
Salva come PNG Salva come JPEG
Nome #
Insights from comparison of serum IgG4 between T2-eosinophilic asthma and eosinophilic granulomatosis with polyangiitis/idiopathic hypereosinophilic syndrome 246
An international SUrvey on non-iNvaSive tecHniques to assess the mIcrocirculation in patients with RayNaud'€™s phEnomenon (SUNSHINE survey) 229
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease 203
The value of admission Troponin I to predict outcomes in suspected infections in elderly patients admitted in Internal Medicine: results from the SOFA-T collaboration, a multi-center study 197
The first outstanding 50 years of “Università Politecnica delle Marche”: Research achievements in life sciences 192
Induction of Scleroderma Fibrosis in Skin-Humanized Mice by Administration of Anti−Platelet-Derived Growth Factor Receptor Agonistic Autoantibodies 187
Development of the optimal touchscreen interface for patients with scleroderma 184
Atrial Fibrillation on Patients with Vascular Dementia: A Fundamental Target for Correct Management 178
Preface 177
Characterization of binding and quantification of human autoantibodies to PDGFRα using a biosensor-based approach 171
Developments in the management of advanced soft-tissue sarcoma –€“ Olaratumab in context 170
Adalimumab modulates angiogenesis in psoriatic skin 169
Erratum: Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance [Radiol med, DOI 10.1007/s11547-014-0419-7] 163
SOFA and qSOFA usefulness for in-hospital death prediction of elderly patients admitted for suspected infection in internal medicine 157
Epitope specificity determines pathogenicity and detectability of anti-platelet-derived growth factor receptor α autoantibodies in systemic sclerosis 157
ANCA-negative EGPA: only eosinophils without vasculitis? Insights from anti-T2 biologics 156
6 and 12 month outcomes in patients following COVID-19-related hospitalization: a prospective monocentric study 156
Agonistic anti-PDGF receptor autoantibodies from patients with systemic sclerosis impact human pulmonary artery smooth muscle cells function in vitro 155
A reactive Oxygen species -mediated loop mantains increased expression of NADPH oxidases 2 and 4 in skin fibroblasts from patients with systemic sclerosis 151
SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective Study 151
Ha-Ras stabilization mediates pro-fibrotic signals in dermal fibroblasts. 149
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 147
B CELL RECEPTOR EDITING IN SCLERODERMA PATIENTS GENERATES PATHOGENIC ANTI-PDGFR AUTOANTIBODIES 146
Biosensor-based Binding Assay for Platelet-Derived Growth Factor Receptor-α Autoantibodies in Human Serum 144
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies 144
Long lasting biological effects of PDGFR agonistic auto-antibodies in scleroderma 143
Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs. 142
The ATTRACT study: screening for the early identification of axial psoriatic arthritis in a cohort of Italian psoriatic patients 141
Hypothalamic-pituitary-adrenal axis disregulation in PrPC-null mice. 141
Analysis of ATP8B4 F436L missense variant in a large systemic sclerosis cohort 141
Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice 138
Echocardiographic predictors of mortality in intermediate-risk pulmonary embolism 138
Impact of atrial fibrillation in critically ill patients admitted to a stepdown unit 135
Effects of prophylactic drug therapies and anti-calcitonin peptide-related monoclonal antibodies on subjective sleep quality: An Italian multicenter study 131
A machine learning analysis to predict the response to intravenous and subcutaneous immunoglobulin in inflammatory myopathies. A proposal for a future multi-omics approach in autoimmune diseases 130
Agonistic antibodies in systemic sclerosis 129
DETECTION OF STIMULATORY ANTI-PDGF RECEPTOR AUTOANTIBODIES BY BIOASSAYS BASED ON DIFFERENT CELL LINES 128
Biologics in inflammatory immune-mediated systemic diseases 128
Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches 128
Improving the EHMRG Prognostic Evaluation of Acute Heart Failure with TAPSE/PASp: A Sequential Approach 127
Risk prediction of clinical adverse outcomes with machine learning in a cohort of critically ill patients with atrial fibrillation 127
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 126
AUTOIMMUNITY TO PDGFR: A RELEVANT PATHOGENIC LINK IN SSc 125
Cloning of agonistic autoantibodies specific for the PDGF receptor from the B-cell repertoire of SSc patients 122
Mycophenolate mofetil-induced colitis in a patient with systemic sclerosis 122
History and scientific production of clinica medica and clinica ematologica in ancona 121
PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis 121
Pathogenic autoantibodies in systemic sclerosis 119
CLONING OF AGONISTIC AUTOANTIBODIES SPECIFIC FOR THE PDGF RECEPTOR FROM THE B CELL REPERTOIRE OF PATIENTSAFFECTED BY SYSTEMIC SCLEROSIS 119
Comment on 'Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?' 119
Immunohistochemical detection and localization of somatostatin receptor subtypes in prostate tissue from patients with bladder outlet obstruction. 118
Detection of typical and atypical bovine spongiform encephalopathy and scrapie prion strains by prion protein motif-grafted antibodies. 118
Contributions of neuronal prion protein on sleep recovery and stress response following sleep deprivation. 117
Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with systemic sclerosis 117
Adeno-associated virus type 5 infection via PDGFRα is associated with Interstitial lung disease in systemic sclerosis and generates composite peptides and epitopes recognized by the agonistic immunoglobulins present in patients with systemic sclerosis 116
BIOLOGIC THERAPY IN INFLAMMATORY IMMUNOMEDIATED SYSTEMIC DISEASES: SAFETY PROFILE 116
Autoantibodies against the platelet-derived growth factor receptor in scleroderma: comment on the articles by Classen et al and Loizos et al. 115
Mechanism of action of agonistic PDGFR auto-antibodies isolated from scleroderma patients 115
Update of EULAR recommendations for the treatment of systemic sclerosis 115
Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin 115
Early administration of tofacitinib in COVID-19 pneumonitis: An open randomised controlled trial 113
The Wnt signalling inhibitor gene, WIF1, is silenced in fibroblasts derived from Systemic Sclerosis patients: role of oxidative stress 113
Putative functional pathogenic autoantibodies in systemic sclerosis 113
Clinical method applied to focused ultrasound: The case of wells’ score and echocardiography in the emergency department: A systematic review and a meta-analysis 113
Common Variable Immunodeficiency in Elderly Patients: A Long-Term Clinical Experience 112
WIF1, A WNT PATHWAY INHIBITOR, IS SILENCED IN SYSTEMIC SCLEROSIS BY DNA DAMAGE: A MECHANISM LINKING DNA DAMAGE TO WNT AND FIBROSIS 111
Influence of TYK2 in systemic sclerosis susceptibility: A new locus in the IL-12 pathway 111
NADPH oxidase, oxidative stress and fibrosis in systemic sclerosis 111
Implementation of EHMRG Risk Model in an Italian Population of Elderly Patients with Acute Heart Failure 110
Detection of typical and atypical BSE and scrapie prion strains by prion protein motif-grafted antibodies. 110
MOTIF-GRAFTED HYBRID POLYPEPTIDES AND USES THEREOF 110
Clusters of Comorbidities in the Short-Term Prognosis of Acute Heart Failure among Elderly Patients: A Retrospective Cohort Study 109
Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance 109
Increased expression of the ectoenzyme CD38 in peripheral blood plasmablasts and plasma cells of patients with systemic sclerosis 107
Reduced type I collagen gene expression by skin fibroblasts of patients with systemic sclerosis after one treatment course with rituximab 107
Reactivation of Hepatitis B Virus Infection Associated with Anti-Tumor Necrosis Factor-α Therapy 107
Isolation and cloning of stimulatory anti-PDGF receptor auto-antibodies from the immunological repertoire of patients with systemic sclerosis 106
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways 105
Replacement and Immunomodulatory Activities of 20% Subcutaneous Immunoglobulin Treatment: A Single-Center Retrospective Study in Autoimmune Myositis and CVID Patients 104
Oxidative stress and the pathogenesis of scleroderma: the Murrell's hypothesis revisited. 103
Development of A Solid Phase Binding Assay For Detection of Conformational Anti-PDGFR Autoantibodies In the Serum of Patients Affected By Scleroderma 103
PDGF receptor as therapeutic and diagnostic target in systemic sclerosis 103
Development of a conformation-dependent immunoassay for the diagnosis of systemic sclerosis 103
Oxidative DNA damage induces the ATM-mediated transcriptional suppressionof the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis 102
Low-dose Oral Imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide. A phase II pilot study 102
Downregulation of GPR83 in the hypothalamic preoptic area reduces core body temperature and elevates circulating levels of adiponectin. 102
Isolation and cloning of stimulatory anti-PDGF receptor auto-antibodies from the immunological repertoire of patients with systemic sclerosis 101
Cutting-Edge Techniques and Drugs for the Treatment of Pulmonary Embolism: Current Knowledge and Future Perspectives 101
Scleroderma-like fibrosis in chronic graft-vs-host disease is sustained by anti-PDGF receptors antibodies 100
Role of viral infections in the etiopathogenesis of systemic sclerosis 100
Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort 99
Delection of typical and atypical bovine spongiform encephalopathy and scraipe prion strains by prion protein motif-grafted antibodies 99
Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets 98
Platelet-activating factor acetylhydrolase: A biomarker in Hymenoptera venom allergy? 98
Treatment With Rituximab Reduces Activation Of Scleroderma Dermal Fibroblasts 97
Development of a conformation-dependent immunoassay for the diagnosis of systemic sclerosis 96
Lack of interleukin-13 receptor α1 delays the loss of dopaminergic neurons during chronic stress 96
Efficacy and safety of intravenous and subcutaneous tocilizumab in a cohort of patients affected by rheumatoid arthritis in real-life 94
Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study 94
Shared Molecular Mechanisms among Alzheimer’s Disease, Neurovascular Unit Dysfunction and Vascular Risk Factors: A Narrative Review 93
Totale 12.847
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.407
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.407
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021356 0 0 0 0 0 0 0 0 0 129 152 75
2021/2022865 44 190 23 29 22 43 20 53 83 57 125 176
2022/20231.821 148 189 128 162 113 403 9 101 382 24 122 40
2023/20241.153 163 38 66 138 167 233 21 51 11 82 57 126
2024/20252.871 319 259 75 48 128 119 345 128 585 190 282 393
2025/20267.956 581 639 650 909 962 516 1.513 782 736 668 0 0
Totale 17.614